1. Home
  2. RIVN vs ILMN Comparison

RIVN vs ILMN Comparison

Compare RIVN & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rivian Automotive Inc.

RIVN

Rivian Automotive Inc.

HOLD

Current Price

$17.96

Market Cap

19.8B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$128.90

Market Cap

18.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RIVN
ILMN
Founded
2009
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.8B
18.9B
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
RIVN
ILMN
Price
$17.96
$128.90
Analyst Decision
Hold
Hold
Analyst Count
20
15
Target Price
$14.79
$114.93
AVG Volume (30 Days)
51.1M
1.5M
Earning Date
11-04-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
4.46
Revenue
$5,835,000,000.00
$4,288,000,000.00
Revenue This Year
$9.72
N/A
Revenue Next Year
$30.31
$2.08
P/E Ratio
N/A
$28.91
Revenue Growth
28.21
N/A
52 Week Low
$10.36
$68.70
52 Week High
$18.60
$153.06

Technical Indicators

Market Signals
Indicator
RIVN
ILMN
Relative Strength Index (RSI) 68.63 66.70
Support Level $16.90 $124.27
Resistance Level $17.79 $129.72
Average True Range (ATR) 0.85 3.90
MACD 0.21 -0.41
Stochastic Oscillator 86.24 77.82

Price Performance

Historical Comparison
RIVN
ILMN

About RIVN Rivian Automotive Inc.

Rivian Automotive Inc is an automotive manufacturer that develops and builds electric vehicles ("EVs") as well as software and services. It launches its consumer vehicle business with the R1 platform consisting of two vehicles: the R1T, and the R1S. The company has two reportable segments: Automotive, which derives the majority of revenue, and Software and Services segment. The Automotive reportable segment derives its revenues and cost of revenues from the production and sale of new EVs and the sale of regulatory credits generated by the production and sale of EVs. The Software and services reportable segment derives its revenues and cost of revenues from remarketing, vehicle repair and maintenance services, and vehicle electrical architecture and software development services.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: